Skip to main content
Article
Care After Lymphoma (CALy) trial: A phase II pilot pragmatic randomised controlled trial of a nurse-led model of survivorship care
European Journal of Oncology Nursing
  • Karen Taylor
  • Paola Chivers
  • Caroline Bulsara
  • David Joske
  • Max Bulsara
  • Leanne Monterosso, Edith Cowan University
Publication Date
1-1-2019
Document Type
Journal Article
Publisher
Elsevier Ltd
School
School of Nursing and Midwifery
RAS ID
31100
Comments

Taylor, K., Chivers, P., Bulsara, C., Joske, D., Bulsara, M., & Monterosso, L. (2019). Care After Lymphoma (CALy) trial: A phase II pilot pragmatic randomised controlled trial of a nurse-led model of survivorship care. European Journal of Oncology Nursing, 40, 53-62. Available here

Abstract

Purpose

Post-treatment follow-up for lymphoma potentially fails to address the supportive care needs of survivors. A nurse-led lymphoma survivorship model of care was developed and tested in a phase II pilot pragmatic randomised controlled trial (RCT). The intervention comprised three face-to-face appointments, delivery of tailored resources and an individualised survivorship care plan and treatment summary (SCPTS), shared with the general practitioner (GP). Method

Three months’ post-treatment completion, eligible lymphoma patients were randomised 1:1 to usual care (control) or usual care plus intervention. Survivorship unmet needs (Short-Form Survivor Unmet Needs Survey), distress (Depression Anxiety Stress Scale 21), adjustment to cancer (Mini-Mental Adjustment to Cancer scale) and self-empowerment (Patient Empowerment Scale) were assessed at baseline, three and six months. Univariate and multivariate analyses examined changes within and between groups at the three time points. A GP evaluation survey sought information on the perceived utility of the SCPTS. Results

Statistical significance was set at 0.05 (2-tailed). Although not statistically significant, by study completion, intervention participants (n = 30), reported less unmet needs (M = 21.41 vs M = 25.72, p = .506), less distress ((M = 13.03 vs M = 15.14, p = .558) and an increase in empowerment (M = 50.21 vs M = 47.21, p = .056) compared with control participants (n = 30). The SCPTS was rated good to very good by a majority of GPs (n = 13, 81%). Conclusions

The nurse-led lymphoma survivorship model of care may be a helpful intervention for lymphoma patients who had completed treatment. Survivors require individualised and tailored support and resources. A tailored SCPTS may promote survivor self-management and increase GP engagement.

Disciplines
DOI
10.1016/j.ejon.2019.03.005
Access Rights
subscription content
Citation Information
Karen Taylor, Paola Chivers, Caroline Bulsara, David Joske, et al.. "Care After Lymphoma (CALy) trial: A phase II pilot pragmatic randomised controlled trial of a nurse-led model of survivorship care" European Journal of Oncology Nursing (2019)
Available at: http://works.bepress.com/caroline_bulsara/93/